Skip to main content
VCbacked
Log inGet Started

Thymmune Therapeutics

Cambridge, United States

Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.

$37.0M raised
Sep 2023
Grant
BiotechnologyTherapeutics

Top Investors

Pillar VCAdvanced Research Projects Agency for HealthArranta BioNYBC VenturesGeorge Church

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Thymmune Therapeutics

How much funding has Thymmune Therapeutics raised?
Thymmune Therapeutics has raised $37.0M in total funding. The most recent round was Grant. The last funding was announced in September 2023.
Who are Thymmune Therapeutics's investors?
Thymmune Therapeutics's investors include Pillar VC, Advanced Research Projects Agency for Health, Arranta Bio, NYBC Ventures, George Church.
Where is Thymmune Therapeutics headquartered?
Thymmune Therapeutics is headquartered in Cambridge, United States.
What does Thymmune Therapeutics do?
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.
What stage is Thymmune Therapeutics at?
Thymmune Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Thymmune Therapeutics — Funding & Investors." VCBacked, September 29, 2023, https://www.vcbacked.co/company/thymmune-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2023). Thymmune Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/thymmune-therapeutics
Wikipedia (cite web)
{{cite web |title=Thymmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/thymmune-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K